Norrsken Mind invites proposals for a pan-European patient registry for psychedelic therapies and real-world evidence

Norrsken Mind is inviting proposals to design a pan-European patient registry for psychedelic therapies, aimed at harmonising real-world data from patients treated through emerging early access programmes and regulatory pathways outside traditional clinical trials. The project will produce a registry blueprint, data framework, and practical implementation plan rather than build the technical platform. Its scope includes objectives, a core data set, outcomes, follow-up, governance, data ownership and access, interoperability, legal and regulatory considerations, treatment delivery, patient outcomes, and safety. The registry should work across substances, treatment models, indications, countries, and healthcare systems, while generating evidence useful to researchers, clinicians, regulators, health technology assessment bodies, and payers. Applicants need experience in patient registries or real-world evidence, and must submit a one-page overview and separate CVs by 11 November 2026.